These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1694224)

  • 1. Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysis.
    Meri S; Morgan BP; Wing M; Jones J; Davies A; Podack E; Lachmann PJ
    J Exp Med; 1990 Jul; 172(1):367-70. PubMed ID: 1694224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential susceptibility of type III erythrocytes of paroxysmal nocturnal hemoglobinuria to lysis mediated by complement and perforin.
    Jiang S; Persechini PM; Rosse WF; Perussia B; Young JD
    Biochem Biophys Res Commun; 1989 Jul; 162(1):316-25. PubMed ID: 2751655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
    Meri S; Morgan BP; Davies A; Daniels RH; Olavesen MG; Waldmann H; Lachmann PJ
    Immunology; 1990 Sep; 71(1):1-9. PubMed ID: 1698710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
    Jiang S; Persechini PM; Perussia B; Young JD
    J Immunol; 1989 Sep; 143(5):1453-60. PubMed ID: 2503557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of cytolytic lymphocytes to perforin-mediated killing. Lack of correlation with complement-associated homologous species restriction.
    Jiang SB; Persechini PM; Zychlinsky A; Liu CC; Perussia B; Young JD
    J Exp Med; 1988 Dec; 168(6):2207-19. PubMed ID: 3199067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells.
    Hakulinen J; Meri S
    Lab Invest; 1994 Dec; 71(6):820-7. PubMed ID: 7528832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.
    Mäenpää A; Junnikkala S; Hakulinen J; Timonen T; Meri S
    Am J Pathol; 1996 Apr; 148(4):1139-52. PubMed ID: 8644856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of protectin (CD59) in human melanoma and its functional role in cell- and complement-mediated cytotoxicity.
    Brasoveanu LI; Altomonte M; Gloghini A; Fonsatti E; Coral S; Gasparollo A; Montagner R; Cattarossi I; Simonelli C; Cattelan A
    Int J Cancer; 1995 May; 61(4):548-56. PubMed ID: 7538980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-idiotypic antibodies derived against C8, C9 and perforin bind homologous restriction factor.
    Young JD; Jiang S; Liu CC; Hasselkus-Light CS
    J Immunol Methods; 1990 Mar; 128(1):133-42. PubMed ID: 1691232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of homologous restriction factor does not affect CTL-mediated cytolysis.
    Krähenbühl OP; Peter HH; Tschopp J
    Eur J Immunol; 1989 Jan; 19(1):217-9. PubMed ID: 2784107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
    Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
    FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
    Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
    Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The homologous restriction factor is immunologically related to complement components C8 and C9 and to lymphocyte pore-forming protein perforin through cysteine-rich domains.
    Young JD; Rosse WF; Hasselkus-Light CS
    Biochem Biophys Res Commun; 1990 Jan; 166(2):648-52. PubMed ID: 2302230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells.
    Yuan FF; Bryant JA; Fletcher A
    Immunol Cell Biol; 1995 Feb; 73(1):66-72. PubMed ID: 7539403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complement-inhibiting protein, protectin (CD59 antigen), is present and functionally active on glomerular epithelial cells.
    Rooney IA; Davies A; Griffiths D; Williams JD; Davies M; Meri S; Lachmann PJ; Morgan BP
    Clin Exp Immunol; 1991 Feb; 83(2):251-6. PubMed ID: 1704296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocytes of patients with paroxysmal nocturnal haemoglobinuria acquire resistance to complement attack by purified 20-kD homologous restriction factor.
    Okada N; Harada R; Okada H
    Clin Exp Immunol; 1990 Apr; 80(1):109-13. PubMed ID: 1691059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of membrane factors other than DAF and CD59 in complement-mediated lysis of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Hatanaka M; Inai S; Matsumoto M; Miyagawa S; Masaoka T; Kanamaru A; Kawakita M; Yonemura Y; Sugita Y; Seya T
    Clin Immunol Immunopathol; 1993 Oct; 69(1):52-9. PubMed ID: 7691453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
    Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
    Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
    Brooimans RA; van Wieringen PA; van Es LA; Daha MR
    Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a novel monoclonal antibody against human perforin using transfected cell lines.
    Schlesinger BC; Cheng L
    Immunology; 1994 Feb; 81(2):291-5. PubMed ID: 8157278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.